13.00

3.77% -0.51

Pre-market: 13.11 0.11 +0.85%

Embecta Corp (EMBC)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Embecta Corp stock is traded at $13.00, with a volume of 669.63K. It is down -3.77% in the last 24 hours and down -19.50% over the past month. Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Previous Close:

$13.51

Open:

$13.55

24h Volume:

669.63K

Relative Volume:

1.45

Market Cap:

$755.75M

Revenue:

$1.12B

Net Income/Loss:

$55.30M

P/E Ratio:

13.68

EPS:

0.95

Net Cash Flow:

$-30.30M

1W Performance:

+0.93%

1M Performance:

-19.50%

6M Performance:

-18.85%

1Y Performance:

-7.08%

1-Day Range:

$12.64

$13.62

1-Week Range:

$12.51

$14.46

52-Week Range:

$9.925

$21.48

Embecta Corp Stock (EMBC) Company Profile

Name

Embecta Corp

Sector

Healthcare (1169)

Industry

Medical Instruments & Supplies (62)

Phone

(862) 401-0000

Address

1209 ORANGE STREET, WILMINGTON

Employee

2,100

Twitter

Next Earnings Date

2024-12-26

Latest SEC Filings

EMBC's Discussions on Twitter

Compare EMBC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EMBC Embecta Corp	13.00	755.75M	1.12B	55.30M	-30.30M	0.95
ISRG Intuitive Surgical Inc	476.78	170.05B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	222.79	63.97B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	86.81	42.94B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	219.72	32.28B	4.93B	1.25B	1.38B	8.47
BAX Baxter International Inc	34.55	17.64B	17.28B	108.00M	391.00M	0.20

Embecta Corp Stock (EMBC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight
Jun-21-22	Initiated	BofA Securities	Underperform

View All

Embecta Corp Stock (EMBC) Latest News

Mar 13, 2025

Bank of New York Mellon Corp Purchases 4,769 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World

Mar 13, 2025

Mar 10, 2025

Analyzing Embecta (NASDAQ:EMBC) and Lucid Diagnostics (NASDAQ:LUCD) - Defense World

Mar 10, 2025

Mar 08, 2025

Oppenheimer Asset Management Inc. Takes $209,000 Position in Embecta Corp. (NASDAQ:EMBC) - Defense World

Mar 08, 2025

Mar 01, 2025

Embecta Insider Ups Holding By 20% During Year - Yahoo Finance UK

Mar 01, 2025

Feb 28, 2025

Embecta corp. director Morris Mayo sells shares worth $50,782 - MSN

Feb 28, 2025

Embecta: Weak Outlook But Mouth-Watering Valuation Skew Risk-Reward In Favour - Seeking Alpha

Feb 28, 2025

Feb 26, 2025

Director Makes Bold Move with Major Stock Purchase in Embecta Corporation - TipRanks

Feb 26, 2025

Feb 25, 2025

Embecta corp. director Melcher buys $177,646 in stock By Investing.com - Investing.com Canada

Feb 25, 2025

Embecta corp. director Melcher buys $177,646 in stock - Investing.com India

Feb 25, 2025

Feb 23, 2025

Where are the Opportunities in (EMBC) - Stock Traders Daily

Feb 23, 2025

New York State Teachers Retirement System Has $1.55 Million Position in Embecta Corp. (NASDAQ:EMBC) - Defense World

Feb 23, 2025

Feb 20, 2025

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference - GlobeNewswire

Feb 18, 2025

MDT: 3 Healthcare IT Stocks Revolutionizing Patient Care - StockNews.com

Feb 18, 2025

Exclusive: Embecta's Strategic Financial Roadmap Unveiled at JP Morgan Conference - StockTitan

Feb 18, 2025

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference - GlobeNewswire Inc.

Feb 18, 2025

Embecta Corp. (NASDAQ:EMBC) Sees Significant Decline in Short Interest - MarketBeat

Feb 18, 2025

Embecta Corp. (NASDAQ:EMBC) Shares Sold by Savant Capital LLC - Defense World

Feb 18, 2025

Feb 17, 2025

Embecta (NASDAQ:EMBC) Stock Price Down 5.7% After Insider Selling - MarketBeat

Feb 17, 2025

Senior Manager, Indirect Sourcing (hybrid) - Built In

Feb 17, 2025

Milton Mayo Morris Sells 3,100 Shares of Embecta Corp. (NASDAQ:EMBC) Stock - MarketBeat

Feb 17, 2025

Feb 15, 2025

Yacktman Asset Management LP Reduces Stock Position in Embecta Corp. (NASDAQ:EMBC) - MarketBeat

Feb 15, 2025

Embecta corp. director Morris Mayo sells shares worth $50,782 By Investing.com - Investing.com Nigeria

Feb 15, 2025

Feb 14, 2025

Embecta Corp. Shareholders Elect Directors, Ratify Auditor - MSN

Feb 14, 2025

Embecta Corp. Shareholders Elect Directors, Ratify Auditor By Investing.com - Investing.com South Africa

Feb 14, 2025

Feb 12, 2025

Diabetes care company Embecta finds perfect shipping partner in UPS - UPS

Feb 12, 2025

Feb 11, 2025

Embecta (NASDAQ:EMBC) Shares Gap DownWhat's Next? - MarketBeat

Feb 11, 2025

Embecta Corp. Announces Quarterly Dividend of $0.15 (NASDAQ:EMBC) - MarketBeat

Feb 11, 2025

Embecta (EMBC) to Release Earnings on Friday - MarketBeat

Feb 11, 2025

Feb 10, 2025